Wilhelm Ansorge (Ecole Polytechnique Fédérale de Lausanne, Switzerland): Genome Analysis Techniques in Medicine and Biology
Marek Basler (Biozentrum, University of Basel, Switzerland): Type VI secretion system: from the discovery to the mode of action of a dynamic bacterial nanomachine
Edward A. Bayer (Department of Biomolecular Sciences, The Weizmann Institute of Science, Israel): Synthetic biotechnology of designer cellulosome systems
Yusuf Chisti (Massey University, New Zealand): Emerging trends in microalgae biotechnology
Peter Dürre (University of Ulm, Germany): Metabolic engineering of anaerobic acetogens for converting greenhouse gases into sustainable products
Lothar Elling (Helmholtz-Institute for Biomedical Engineering, Germany): The Golgi Glycan Factory (GGF) - Enzyme Modules for Glycoconjugate Synthesis
László Forró (Ecole Polytechnique Fédérale de Lausanne, Switzerland): Infrared spectroscopic and machine learning investigation of multiple sclerosis: human case versus animal model
Kresimir Gjuracic (Gnosis by Lesaffre, Italy): Today’s awareness of Vitamin K2 biological importance, after an almost century of it’s discovery
Ulf Grawunder (NBE-Therapeutics Ltd., Switzerland): NBE’s immune-stimulatory Antibody Drug Conjugates for cancer therapy – the old “Magic bullet” concept in new clothes
Flavia Marinelli (University of Insubria, Italy): Where will novel antibiotics come from in nature?
Martin Pumera (Center for the Advanced Functional Nanorobots, Czech republic): Nanorobots: Machines Between Cells and Viruses
Hong-Wei Yen (Tunghai University, Taiwan): The current development status of microalgae study in Taiwan
Scope of the session: The session will cover modern biotechnological approaches to new drug discovery, drug innovation and other development concerning this area. Contributions on identification, screening, and characterization of biological activities of synthetic or natural compounds, secondary or specialized metabolites (antibiotics, immunosuppressors, antitumors, antivirotics etc.), bioactive peptides and proteins (enzymes, vaccines) are especially welcome. Novel approaches in production of active compounds, including recombinant and fermentation technologies, new methods and assays for their testing and evaluation either in cell-based systems or in vitro are accepted.
Keywords: drug discovery and innovation, natural products, secondary (specialized) metabolites, recombinant peptides and proteins, cell-based methods, in vitro methods
Scope of the session: The Food and Agriculture Biotechnology session will focus on sustainable food production (raw materials, processing, packaging, storage); food quality/safety and food adulteration. Presentations are welcome on the detection and control of spoilage and pathogenic microorganisms; development and applications of novel enzymes; functional foods with new and improved properties; nutritional supplements with value added output traits; development of food and agricultural products with new properties by genetic engineering. A particular area of interest is application of biotechnology in agriculture.
Keywords: food production, quality, safety, adulteration, control of pathogenic microorganisms, novel enzymes, functional foods, nutritional supplements, genetic engineering, biotechnology in agriculture
Scope of the session: This session focuses on the understanding and improvement of key parameters such as cell growth, cell metabolism, productivity and product quality, which are crucial in industrial process design. Contributions related to technologies and methods utilizing bacteria, yeast, algae or mammalian cells as host organisms are welcome. Other relevant topics include, e.g., high throughput screening methods, cell factories or the development and optimization of upstream process models in both fed-batch and continuous operation. This session also covers novel methodologies of synthetic biochemistry and biology leading to products prospective for efficient large-scale synthesis. A special attention is devoted to the use of enzymes as synthetic or analytical tools.
Keywords: cell factory, cell metabolism, enzymatic synthesis, high throughput screening, synthetic biology, upstream process model
Scope of the session: This session spans all aspects of microalgae biotechnology. Of particular interest are products from microalgae; photobioreactors and other technologies for large-scale production of microalgal biomass; the methods of harvesting microalgae; downstream processing of algal biomass for product recovery; and the use of algae in environmental applications. Contributions on potential algal biofuels and biorefineries based on microalgae are particularly welcome.
Keywords: microalgae, bioproducts, biofuels, biorefineries, production of algal biomass, downstream processing, environmental applications of microalgae
Scope of the session: The session is focused on the study and use of biological systems for remediation of contaminated environments - land, air and water. The aim is to show recent development and achievements in the use of biotechnological tools such as engineered microbial consortia or task-specific application of strains and enzymes for environmental protection. Special attention will be paid to material and energy recovery from waste and wastewater in accordance with principles of circular economy.
Keywords: anaerobic digestion, biorefineries, circular economy, environmental protection, waste valorisation
Scope of the session: This section will consider studies that focus on all kinds of plant research with application potential covering the topics from the structure and functionality of plant cells and genes, the effects of adverse conditions on plant growth and development and molecular mechanisms involved in these processes to synthetic biology including techniques of genetic manipulations for development of transgenic plants. Applications of these techniques to maximize plants´ productive capacity and resistance to biotic or abiotic stresses are also welcome.